ANIMATION

Vasopressin V2-Receptor Blockage

Share this animation:

Hyponatremia is a condition characterized by low sodium concentration in blood serum. This may be caused by overactivity of anti-diuretic hormone, which results in increased reabsorption of water from the collecting duct. Tolvaptan is an FDA-approved antagonist of the vasopressin V2-receptor. Inhibition of this receptor prevents the expression of aquaporin channels along the collecting duct, promoting diuresis and correcting sodium levels in serum.

Share It:
Contact XVIVO

Client


Otsuka

The team at XVIVO helped to bring the Quantum Cell Expansion System to life! Their talented group of individuals coalesced to form a responsive, accountable, flexible and creative team that delivered an amazing final product – exceeding our expectations. The first showing of the video to a gathering of senior business leaders within the organization met with kudos and loud applause! We plan to leverage the animation in customer presentations, conferences, and marketing opportunities of all stripes and colors. I would strongly recommend XVIVO and look forward to future projects.

Global Marketing Manager, Quantum Cell Expansion System, CaridianBCT
Share this animation: